Been watching the share price and have to |
@cayers |
04/11/2023 4:24:43 AM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Dr. Sergio Giralt to Discuss Positive Result |
@ |
02/27/2023 1:05:46 PM |
Results were definitely FDA approvable. Everyone is |
@sal32647 |
02/22/2023 6:38:21 PM |
What's wrong? I don't understand! Down 5$ in |
@jaustin1317 |
02/22/2023 6:26:34 PM |
PUMP & DUMP |
@Jackie2021 |
02/21/2023 9:41:37 PM |
Seems controlled |
@MWjunkaccount |
02/21/2023 2:45:07 PM |
$ATNM PR makes me think I missed something. |
@jeremywalker |
02/19/2023 5:17:20 PM |
nice run in progress. My |
@StockLoans |
02/17/2023 1:17:18 PM |
Just thought I would drop this info on |
@Pmc87 |
12/31/2022 8:50:36 PM |
Damn.. in MY message that I |
@Ksokolow988 |
12/04/2022 12:03:50 PM |
Definitely agree that some of the shine is |
@unitedautosales |
11/22/2022 6:50:34 PM |
OK, gave up my shares to the covered calls. |
@bcduff12 |
11/21/2022 7:21:59 PM |
But imagine if you were one of the |
@precisionairgunammo |
11/04/2022 2:26:11 PM |
It will see the target price IF its |
@ohmyhemp |
11/04/2022 2:25:42 PM |
Got to acknowledge, its NOT the company's fault |
@k1cohen |
11/04/2022 2:18:39 PM |
(Also a novice posting). Im just posting on |
@mnmlatesttrends |
11/04/2022 1:46:27 PM |
I'm a novice (at best) in this, but |
@Babubd |
11/04/2022 9:21:32 AM |
I hate to turn into that guy who |
@wazzat1961 |
11/03/2022 11:35:01 PM |
Got an email from $ATNM this morn talking |
@cobbleg |
11/03/2022 4:27:02 PM |
Market valuation, it is what they think the |
@leopold |
11/03/2022 1:25:46 PM |
doubt someone will buy them out for the |
@GoMotopia |
11/03/2022 1:24:17 PM |
I had $30 (minimum) as a price target |
@DES09 |
11/03/2022 1:21:39 PM |
Thats the price it would achieve on approval |
@Stonecold237 |
11/03/2022 1:19:13 PM |
Hey, capping my gains is not a bad |
@Joewharton2 |
11/03/2022 1:17:56 PM |
Cheers - I'd take a buyout. Would actually |
@pellepelle |
11/03/2022 8:31:57 AM |
My price target still stands at $20 short |
@thane |
11/02/2022 4:09:39 PM |
whytestocks: $ATNM News Article - Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Office |
@ |
11/02/2022 12:25:53 PM |
You say 70% accurate as to your price |
@denser111 |
11/02/2022 10:23:54 AM |
You will surely see those number most definitely |
@Wmiez13 |
11/02/2022 2:42:09 AM |
Ill settle for 20-25 by year end |
@Libertex |
11/02/2022 2:40:10 AM |
Maybe it will, maybe it won't. Will |
@Martin |
11/02/2022 2:25:53 AM |
No chance |
@palhivan |
11/02/2022 2:22:43 AM |
znewcar1: $ATNM 39% v8,6M C13.54 f25,2M H13.89 nice |
@fiddlesticks971 |
11/01/2022 2:10:24 AM |
20 late this week or early next week. |
@COOPER123 |
10/31/2022 10:39:38 PM |
Actinium shares are trading higher after the company |
@Richard646 |
10/31/2022 5:22:39 PM |
znewcar1: $ATNM 29% v3M c12.62 f25,184M H12.74 LL4.41 ML6.78 getting into clear skies. |
@nikkidog |
10/31/2022 4:54:14 PM |
whytestocks: $ATNM News Article - Why Is Getty Images (GETY) Stock Up 33% Today? |
@ |
10/31/2022 4:35:54 PM |
whytestocks: $ATNM News Article - Actinium (ATNM) Stock Pops on Positive Trial Results |
@ |
10/31/2022 3:55:50 PM |
whytestocks: $ATNM News Article - Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial |
@ |
10/31/2022 1:50:50 PM |
Im sorry it didnt pan out for you. |
@cynthialombardi14 |
10/31/2022 1:26:04 PM |
You don't think we'll see a run up |
@homefashion |
10/31/2022 1:25:13 PM |
Well now, if someone has an 'award' for |
@marieburdon |
10/31/2022 1:02:29 PM |
Actinium Announces Positive Top-line Results from Pivotal Phase |
@JohnBonesJones |
10/31/2022 12:25:15 PM |
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Actinium |
@MJR4826 |
10/31/2022 10:25:39 AM |
Perhaps the first to be beaten down ( |
@cajundell |
10/27/2022 2:44:41 PM |
Up 30 cents pre on less than 3000 |
@nikhild1 |
10/27/2022 1:34:54 PM |
Agree, hate it when companies 'dilute' even tho |
@coinvigilante |
10/27/2022 4:49:19 AM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals to Participate in the 2022 Bio-Europe Conference |
@ |
10/26/2022 3:15:55 PM |
whytestocks: $ATNM News Article - Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data fo |
@ |
10/25/2022 4:21:11 PM |
Thank you for the information. I really |
@qtdad |
10/24/2022 5:56:52 PM |
Just took a glance at the current outstanding |
@peterjen |
10/24/2022 3:42:59 AM |
You may very well get your wish before mine.. |
@taheri1362 |
10/21/2022 1:40:52 PM |
If only I had dry powder. Id |
@erictili11 |
10/20/2022 1:59:35 AM |
Would like to see $5/sh again before it |
@btstttct10 |
10/19/2022 11:44:07 PM |
The calm before the storm perhaps? Waiting |
@fente |
10/18/2022 6:11:56 PM |
Is a quiet board the last few weeks! |
@MickGO |
10/17/2022 7:08:44 AM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides |
@ |
09/21/2022 3:09:46 PM |
A little bit of profit taking on the |
@rgordon908 |
09/06/2022 9:32:03 PM |
Nice trends leading up to a strong q4 |
@stocksandstuff |
08/31/2022 8:03:20 PM |
Slide 13 at this link has the latest |
@BigBull |
08/25/2022 3:27:55 AM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreemen |
@ |
04/12/2022 2:25:54 PM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Highlights Potent Anti-Tumor Activity of a HER3 Target |
@ |
04/11/2022 7:50:51 PM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Presents Preclinical Data at AACR Showing HER3 Targete |
@ |
04/11/2022 7:40:50 PM |
whytestocks: $ATNM News Article - Actinium Announces Several Presentations from the Phase 3 SIERRA Study of Iomab |
@ |
06/03/2021 8:15:51 PM |
whytestocks: $ATNM News Article - Actinium Strengthens Leadership Team with Appointment of Dr. Avinash Desai as E |
@ |
11/19/2020 2:51:08 PM |
whytestocks: $ATNM News Article - 100% Remission Rate Reported in Third Dose Cohort of Actimab-A CLAG-M Phase 1 C |
@ |
11/04/2020 5:40:48 PM |
whytestocks: $ATNM News Article - Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Bil |
@ |
10/21/2020 3:00:47 PM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals, Inc. Expands R&D Capabilities with New Research Facil |
@ |
10/14/2020 5:35:50 PM |
whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Successful Completion of Planned Phase 1 Act |
@ |
09/14/2020 12:25:48 PM |
EmergingGrowth: ATNM https://emerginggrowth.com/could-covid-19-concerns-be-helping-to-drive-sales-of-glucose-heal |
@Beavis20 |
08/11/2020 1:35:19 PM |
JJ Rotten: .60 pre market...Sweet! |
@Ph1lk |
07/22/2020 12:19:04 PM |
JJ Rotten: Moving Bobby ! wowser ! |
@News |
07/22/2020 10:03:27 AM |
znewcar1: ATNM 39% v93,2M c.4474 f303,3M H.53 S.4253 |
@spsiege |
06/09/2020 8:40:07 PM |
znewcar1: ATNM 30% v80,8M c.290 f303,3M H.32 S.27 |
@kyle2423 |
06/04/2020 8:51:50 PM |
JJ Rotten: .29/.30....Hope your still holding bob....New price target of $3.00. |
@tjtruth |
06/04/2020 12:04:31 PM |
JJ Rotten: Go Baby Go.....25/26 pre market. |
@ecraftindia |
06/04/2020 10:37:59 AM |
znewcar1: ATNM 42% v20M c.30939 f162M H .035 S.29ish |
@Laolieu |
10/24/2019 8:24:20 PM |
whytestocks: $ATNM News Article - Actinium Announces Participation at the 2019 Cell & Gene Meeting on the Mesa |
@ |
09/30/2019 3:25:42 PM |
whytestocks: $ATNM News Article - Actinium Announces Iomab-B Poster Selected for Honorable Distinction Award at t |
@ |
09/23/2019 1:00:51 PM |
whytestocks: $ATNM News Article - Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial |
@ |
07/23/2019 2:35:42 PM |
whytestocks: $ATNM News Article - Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to |
@ |
05/16/2019 4:55:41 PM |
whytestocks: $ATNM News Article - Actinium's Leading Clinical, Preclinical, Production and IP Efforts Related to |
@ |
04/08/2019 7:20:40 PM |
whytestocks: $ATNM News Article - Actinium Successfully Completes Second Module of Collaborative Research Program |
@ |
03/29/2019 3:10:41 PM |
whytestocks: $ATNM News Article - Actinium Highlights its Participation at the Upcoming Targeted Alpha Therapy In |
@ |
03/26/2019 3:10:44 PM |
znewcar1: 16.07% v4,459,709 c.650000 f115,703,044 late afternoon vol |
@rhoffman |
02/20/2019 9:55:40 PM |
znewcar1: 19% 5.9M C.6925 yesterday found support @.576 |
@Stella01wilson |
06/20/2018 8:45:42 PM |
znewcar1: 25% 6.6M C.6279 |
@cxj000100befr |
06/18/2018 8:06:12 PM |
arbo99: As a new investor in ATNM I have done a great deal of DD. It seems their biggest problem has been pa |
@arbo99 |
04/05/2018 12:40:28 PM |
2718: This Co will be over $9.00 by April |
@cmainer |
10/04/2017 6:21:49 PM |
2718: We can HOPE for an 8k this am.Abstracts truly need to be NEW |
@MICHELHAK |
09/14/2017 8:48:03 AM |
2718: Armistice is SHORT w' all those new shiny 4M shares along w' KCG & CDEL. Question is do they just e |
@tomraihansar21 |
08/12/2017 8:39:17 PM |
BooDog: Shelf registration filed. A buying opportunity imo. We should be seeing the 10-Q very soon as well |
@Hornet123 |
07/28/2017 10:43:48 AM |
BooDog: $ATNM just may have found its support for the bounce. |
@Leo |
07/27/2017 2:12:54 PM |
Teej: Trev4 from twits. Gonna hang a hat here. Left ihub cause it was full of numbskulls 2 years ago. Join |
@vikassingh55 |
07/20/2017 11:45:25 PM |
BooDog: A little pre market action teasing here. |
@texanmzungu |
07/11/2017 12:16:44 PM |
BooDog: Gap filled from February. |
@rsamuelsen |
06/14/2017 3:54:31 PM |
BooDog: Showing breakout potential. As well as SYN. |
@bbeglinger |
06/03/2017 5:14:56 PM |
BooDog: Event: Hematologic Malignancies: New Therapies and the Evolving Role of Transplant 2017, Chicago, Il |
@kyliebounce |
03/15/2017 7:22:34 PM |
BooDog: Actinium Announces Expansion of Intellectual Property Portfolio with Notice of Allowance for U.S. Pa |
@kyliebounce |
02/28/2017 12:13:15 PM |
BooDog: Took some off 1.67. Like to see it cut through 1.70 again and hold that for support but needed to t |
@Lazada89 |
02/09/2017 4:21:22 PM |